Clinical trials

  • Cefiderocol for End-stage renal disease (patients on peritoneal dialysis)
  • Lenvatinib for Squamous non-small cell lung cancer|Hepatocellular carcinoma
  • DAPAGLIFLOZIN for Heart failure
  • Cholecalciferol (colecalciferol) for Transient hypercalciuria
  • MODIFIED VACCINIA ANKARA – BAVARIAN NORDIC LIVE VIRUS for Monkeypox (mpox)
  • 2-METHOXY-N-{4-METHOXY-6-[(1H-PYRAZOL-1-YL)METHYL]-1,2-BENZOXAZOL-3-YL}BENZENE-1-SULFONAMIDE for Hormone receptor-positive HER2-negative advanced/metastatic breast cancer
  • Regorafenib for Colorectal adenocarcinoma (stage IV) — no evidence of disease (NED)
  • OXYTOCIN for Healthy children
  • RIFAMPICIN for Tuberculosis (drug-susceptible pulmonary and extrapulmonary)
  • Avalglucosidase alfa for Pompe disease | Glycogen storage disease type II
  • DURVALUMAB for Metastatic breast cancer
  • Triamcinolone acetonide for Chronic shoulder pain